ArticleInternational journal of oncology2018

Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway.

Aeyung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.